Concepedia

Publication | Closed Access

Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.

DOI

218

Citations

18

References

1994

Year

Prudence A. Francis, James R. Rigas, Mark G. Kris, Katherine M.W. Pisters, John Orazem, Karen Woolley, R T Heelan
Journal of Clinical Oncology

Abstract

At this dose and schedule, docetaxel demonstrates significant antitumor activity in patients with advanced NSCLC. Further investigations of this agent in NSCLC are indicated.

References

YearCitations

Page 1